Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 9/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | BRAF | P15056 | 2/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8464833 | 0.89 | MCL1 (0.35) | MCL1TP53TSHRMAPTPGR | |
| SCHEMBL8466103 | 0.84 | MCL1 (0.36) | MCL1TP53TSHRMAPT | |
| SCHEMBL8464575 | 0.82 | MCL1 (0.35) | MCL1TP53TSHRMAPT | |
| SCHEMBL8190792 | 0.80 | AR (0.39) | SLC22A12PGRBRD4 | |
| SCHEMBL8700190 | 0.78 | SLC22A12 (0.33) | SLC22A12MCL1 | |
| SCHEMBL8700195 | 0.78 | SLC22A12 (0.33) | SLC22A12MCL1 | |
| SCHEMBL8461149 | 0.78 | AR (0.33) | MCL1BRAFBRD4 | |
| SCHEMBL1574267 | 0.77 | AR (0.38) | SLC22A12 | |
| SCHEMBL8465633 | 0.76 | AR (0.37) | SLC22A12PGRJAK2BRD4 | |
| SCHEMBL3555928 | 0.74 | TSHR (0.34) | TP53TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998028280-A1 | CERTAIN 3-[2,4-DISUBSTITUTED-5-(SUBSTITUTED AMINO)PHENYL]-1-SUBSTITUTED-6-TRIFLUOROMETHYL-2,4-(1H,3H)-PYRIMIDINEDIONE DERIVATIVES AS HERBICIDES | FMC CORPORATION (US) | 1998-07-02 | — | — | WO | disclosed |